GHK-Cu in underarm creams: real peptide science or beauty marketing?

What's this video probably claiming?

Based on the caption and hashtags, this TikTok is promoting a product called Nadiv Beauty Smooth and Glow Underarm Cream, marketed under the Indonesian hashtag pencerahketiak (underarm brightening). The creator is almost certainly claiming the product lightens, smooths, or brightens underarm skin. Given that this video has been flagged under the peptide category, the product likely contains or claims to contain GHK-Cu (copper tripeptide-1), a peptide that has genuine research behind it for skin remodeling. The framing is probably that this peptide ingredient makes the cream clinically superior to standard cosmetic whitening products. The urgency language ("finally launch," "buruan CO" meaning rush to order) is classic limited-availability pressure, which should make any careful buyer slow down rather than speed up.

What does the science actually show?

GHK-Cu is a naturally occurring copper-binding tripeptide with a real body of research. Pickart et al. (2015, Journal of Aging Science) documented its role in stimulating collagen synthesis, activating antioxidant enzymes, and modulating inflammatory genes. A 2012 study by Finkley et al. in the Journal of Cosmetic Dermatology found that a 1% GHK-Cu formulation applied twice daily for 12 weeks improved skin laxity scores and reduced fine lines in facial skin. The mechanism involves upregulation of collagen I, III, and decorin. However, almost all of this research was conducted on facial or body skin under controlled conditions, with standardized concentrations and vehicle formulations. Underarm skin is distinct: it has higher follicular density, apocrine glands, and chronic friction, and no peer-reviewed trial has specifically tested GHK-Cu for axillary hyperpigmentation. The ingredient is real. The specific application claim is extrapolated, not proven.

Where does the social media noise diverge from clinical reality?

TikTok beauty content routinely takes a legitimate peptide ingredient and implies it delivers dramatic, fast visible results in a consumer cosmetic format. Three problems with that narrative stand out. First, cosmetic products sold over the counter are typically formulated at concentrations far below those used in clinical studies. A 1% GHK-Cu concentration used in the Finkley trial costs significantly more to formulate than what a mass-market underarm cream price point allows. Second, underarm brightening claims in the Indonesian market often involve compounds like niacinamide, alpha-arbutin, or kojic acid, and if those are the actual active ingredients, attributing the brightening effect to a peptide is misleading. Third, peptide stability in cream formulations is a real manufacturing challenge. Copper tripeptides degrade at high temperatures and in certain pH ranges. Without stability testing data, any peptide claim on a cream is at best aspirational.

What should you actually know?

GHK-Cu has genuinely interesting science behind it, particularly for skin barrier repair and collagen support. That is not in dispute. What is in dispute is whether a commercially launched underarm cream, promoted with urgency-sale tactics on TikTok, actually delivers a therapeutic concentration of a stable peptide to axillary tissue. Consumers in Indonesia and globally deserve to know that "contains peptides" in a beauty product label is not regulated the same way pharmaceutical claims are. No regulatory body, including BPOM (Indonesia's FDA equivalent), requires proof of peptide efficacy for cosmetic classification. If you are interested in GHK-Cu for skin health, the evidence supports topical concentrations of at least 0.5-1%, in a formulation validated for stability, applied consistently for 8-12 weeks. A TikTok launch video with countdown pressure tells you nothing about whether this product meets those standards. Ask for the certificate of analysis before you order.